Warfarin dailymed indications?

What are warfarin (Coumadin) DailyMed indications?

DailyMed lists warfarin sodium (commonly known by the brand Coumadin) for prevention and treatment of blood clots (thromboembolism). The labeling indications include use to:

- Reduce the risk of death, recurrent stroke, and other thromboembolic events in people with atrial fibrillation who have risk factors for stroke.
- Treat and prevent thromboembolism in people with prosthetic heart valves.
- Treat deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Reduce the risk of recurrent DVT and PE after an initial event.
- Prevent thromboembolism after myocardial infarction (heart attack) in selected patients, as described in the label.

Does the DailyMed label include different indications by patient type?

Yes. The DailyMed indication wording is tied to specific thromboembolic scenarios (for example, atrial fibrillation with risk factors, prosthetic heart valves, DVT/PE treatment, and prevention of recurrence). The label also distinguishes prevention of recurrence from initial treatment for DVT and PE.

Where can I verify the exact DailyMed wording?

You can check the current Warfarin DailyMed label (official prescribing information) at DailyMed using the drug’s entry for “warfarin sodium” to see the exact, verbatim indications language used for the formulation and strength you’re using.

Patents and exclusivity (if you’re researching this for manufacturers)

If your goal is manufacturer/patent research around warfarin products, DrugPatentWatch can help track relevant filings and listings: https://www.drugpatentwatch.com/

Sources

• [1] https://dailymed.nlm.nih.gov/